Showing 751 - 760 of 1,415
Objective: The objective of this study was to conduct an economic evaluation to identify any differences in the expected costs and outcomes between patients treated with pulmonary artery catheters (PACs) and those without, in order to better inform healthcare decision makers. Method: The...
Persistent link: https://www.econbiz.de/10005590263
Objective: To assess the cost effectiveness of aspirin 25mg plus dipyridamole 200mg twice daily in the secondary prevention of ischaemic stroke, according to the French social security perspective, using efficacy data from the second European Stroke Prevention Study (ESPS-2). The ESPS-2 was a...
Persistent link: https://www.econbiz.de/10005590269
DOI: 10.2165/0019053-200826100-00008
Persistent link: https://www.econbiz.de/10005590278
Objective: To develop a user-friendly tool for managing the transfer of economic evaluation results. Methods: Factors that may influence the transfer of health economic study results were systematically identified and the way they impact on transferability was investigated. A transferability...
Persistent link: https://www.econbiz.de/10005590281
Aromatase inhibitors (AIs) have been evaluated clinically in a wide range of breast cancer treatment settings. Although these agents appear to have clinical superiority, they are more expensive than the therapies (primarily tamoxifen) they have been compared with, thus economic evaluation is...
Persistent link: https://www.econbiz.de/10005590282
Introduction: The aim of this study was to evaluate the cost effectiveness of glaucoma treatment with bimatoprost compared with other intraocular pressure (IOP)-lowering medications in adult patients with chronic glaucoma or ocular hypertension (IOP of between 22mm Hg and 34mm Hg), from a US...
Persistent link: https://www.econbiz.de/10005590286
Introduction: The objective of this study was to assess the cost effectiveness of a continuous combined oral preparation of norethisterone (norethindrone) acetate and ethinylestradiol (NA/EE) [FemHRT(R)] as both a first-line and second-line therapy for menopausal women. Perspective: Third-party...
Persistent link: https://www.econbiz.de/10005590287
Glaucoma is a common ophthalmic condition, often associated with elevated intraocular pressure (IOP). It affects 2 million people in the US, and the incidence is expected to exceed 3 million by 2020. However, relatively little is known about the cost of glaucoma compared with costs for other eye...
Persistent link: https://www.econbiz.de/10005590288
Overactive bladder is a common condition, with recent findings estimating the prevalence in adults at about 15%. Symptoms, including urinary urgency, high voiding frequency and urge incontinence, have been shown to decrease patients' quality of life. Given its high prevalence, the economic...
Persistent link: https://www.econbiz.de/10005590290
Clopidogrel (Plavix(R)) is a selective inhibitor of adenosine diphosphate-induced platelet aggregation. In patients with acute coronary syndromes (ACS) [unstable angina or non-ST-segment elevation myocardial infarction], clopidogrel plus aspirin (acetylsalicylic acid) for up to 1 year...
Persistent link: https://www.econbiz.de/10005590293